Key Drivers and Market Trends
The advent of technological innovations in oligonucleotide synthesis and the surging research activities in the pharmaceutical and biotechnology sectors has boosted the market advancement of the oligonucleotide synthesis market globally. The oligonucleotide synthesis market across the globe is predicted to witness market growth of USD 2,870.69 million through 2022 and 2027. It is forecasted the market will exhibit growth at a CAGR of 13.47%.
Navigating through the market drivers of oligonucleotide synthesis: When it comes to the growth drivers it includes factors like
"Technavio's research report lists all the growth drivers that are likely to boost market growth along with a detailed analysis of the market segments, trends, and challenges that are likely to impact market growth."
Market Trends: As per the current market trends rise in demand for cost-effective and high-throughput oligonucleotide synthesis is a primary trend in the oligonucleotide synthesis market. Production of large-scale desired gene sequences at cost-effective prices will enable rapid progress in both fundamental and applied biological research.
Oligonucleotide Synthesis Market: Segments and Geographical Regions
Key Companies: Major market players in this segment comprise names like Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., etc. Our report includes qualitative and quantitative analyses of vendors with a wider understanding of the business ecosystem. Download a Sample Report